From: A prediction model for the grade of liver fibrosis using magnetic resonance elastography
Characteristic | Patients (n = 184) |
---|---|
Age, yr | 69 (42–91) |
Male, n (%) | 130 (70.6) |
Background liver disease, n (%) | |
Non-B non-C liver | 103 (55.9) |
Hepatitis B | 35 (19.0) |
Hepatitis C | 46 (25.0) |
Body mass index, kg/m2 | 22.8 (14.4–37.1) |
ASA grading, n (%) | |
Grade 1 | 65 (35.3) |
Grade 2 | 116 (63.0) |
Grade 3 | 3 (1.6) |
History of hepatic resection, n (%) | 48 (26.0) |
Hemoglobin, g/dL | 13.0 (8.2–16.9) |
White blood cell count, 109/L | 5.1 (2.3–12.1) |
Platelet count, 109/L | 17.2 (4.8–43.5) |
Total bilirubin, mg/dL | 0.59 (0.24–1.48) |
Aspartate aminotransferase, U/L | 28 (11–170) |
Alanine aminotransferase, U/L | 23 (6–271) |
PT-INR | 0.99 (0.85–1.36) |
Albumin, g/L | 3.9 (2.3–4.8) |
Hyaluronic acid, ng/mL | 62 (12–737) |
IV core 7S, ng/mL | 5.8 (3.2–13.0) |
Child-Pugh classification, n (%) | |
A | 178 (96.7) |
B | 6 (3.2) |
ICGR15, % | 12.2 (3.4–33.0) |
LSM value by MRE, kPa | 3.3 (1.4–11.2) |